IN2014MN02133A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN02133A IN2014MN02133A IN2133MUN2014A IN2014MN02133A IN 2014MN02133 A IN2014MN02133 A IN 2014MN02133A IN 2133MUN2014 A IN2133MUN2014 A IN 2133MUN2014A IN 2014MN02133 A IN2014MN02133 A IN 2014MN02133A
- Authority
- IN
- India
- Prior art keywords
- composition
- treatment
- arformoterol
- prevention
- preparing
- Prior art date
Links
- 239000000203 mixture Substances 0.000 abstract 2
- BPZSYCZIITTYBL-YJYMSZOUSA-N R-Formoterol Chemical compound C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-YJYMSZOUSA-N 0.000 abstract 1
- 229960001692 arformoterol Drugs 0.000 abstract 1
- 229960001469 fluticasone furoate Drugs 0.000 abstract 1
- XTULMSXFIHGYFS-VLSRWLAYSA-N fluticasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(F)[C@@]4(C)C=CC(=O)C=C4[C@@H](F)C[C@H]3[C@@H]2C[C@H]1C)C(=O)SCF)C(=O)C1=CC=CO1 XTULMSXFIHGYFS-VLSRWLAYSA-N 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000000414 obstructive effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2133MUN2014 IN2014MN02133A (de) | 2012-04-11 | 2013-04-10 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1179MU2012 | 2012-04-11 | ||
| PCT/GB2013/000161 WO2013153349A2 (en) | 2012-04-11 | 2013-04-10 | Pharmaceutical composition |
| IN2133MUN2014 IN2014MN02133A (de) | 2012-04-11 | 2013-04-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02133A true IN2014MN02133A (de) | 2015-10-09 |
Family
ID=48143313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2133MUN2014 IN2014MN02133A (de) | 2012-04-11 | 2013-04-10 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9402854B2 (de) |
| EP (1) | EP2836198A2 (de) |
| JP (2) | JP2015512929A (de) |
| KR (1) | KR20150002774A (de) |
| CN (1) | CN104271112A (de) |
| AU (2) | AU2013246692A1 (de) |
| CA (1) | CA2869355A1 (de) |
| IN (1) | IN2014MN02133A (de) |
| MX (1) | MX2014011576A (de) |
| RU (1) | RU2678992C2 (de) |
| WO (1) | WO2013153349A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2869355A1 (en) | 2012-04-11 | 2013-10-17 | Cipla Limited | Pharmaceutical composition |
| CN111467498A (zh) * | 2020-05-14 | 2020-07-31 | 王兆霖 | 药物组合物制剂 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9700135D0 (sv) | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| US6458338B1 (en) * | 1998-09-22 | 2002-10-01 | Aeropharm Technology Incorporated | Amino acid stabilized medicinal aerosol formulations |
| DE19847969A1 (de) * | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Lagerfähig flüssige Formulierung mit Formoterol |
| GB9903759D0 (en) | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
| US6369115B1 (en) * | 2000-03-20 | 2002-04-09 | Dura Pharmaceuticals, Inc. | Stabilized powder formulations |
| GB0009591D0 (en) | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Medical combinations |
| FI20002216A0 (fi) | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit astman hoitoon |
| US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| DE10228103A1 (de) | 2002-06-24 | 2004-01-15 | Bayer Cropscience Ag | Fungizide Wirkstoffkombinationen |
| WO2004028545A1 (en) | 2002-09-25 | 2004-04-08 | Astrazeneca Ab | A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES |
| SE527200C2 (sv) | 2003-06-19 | 2006-01-17 | Microdrug Ag | Inhalatoranordning samt kombinerade doser av formaterol och fluticason |
| WO2009147383A1 (en) * | 2008-06-02 | 2009-12-10 | Cipla Limited | Process for the synthesis of arformoterol |
| GB0918150D0 (en) | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved formulations |
| WO2011136753A1 (en) * | 2010-04-26 | 2011-11-03 | Mahmut Bilgic | Combination of carmoterol and fluticasone for use in the treatment respiratory diseases |
| WO2012010854A1 (en) * | 2010-07-23 | 2012-01-26 | Cipla Limited | Inhalation formulations comprising carmoterol in combination with a corticosteroid |
| CA2869355A1 (en) | 2012-04-11 | 2013-10-17 | Cipla Limited | Pharmaceutical composition |
-
2013
- 2013-04-10 CA CA2869355A patent/CA2869355A1/en not_active Abandoned
- 2013-04-10 RU RU2014144145A patent/RU2678992C2/ru not_active IP Right Cessation
- 2013-04-10 WO PCT/GB2013/000161 patent/WO2013153349A2/en active Application Filing
- 2013-04-10 CN CN201380019244.8A patent/CN104271112A/zh active Pending
- 2013-04-10 US US14/389,684 patent/US9402854B2/en not_active Expired - Fee Related
- 2013-04-10 AU AU2013246692A patent/AU2013246692A1/en not_active Abandoned
- 2013-04-10 KR KR20147031205A patent/KR20150002774A/ko not_active Application Discontinuation
- 2013-04-10 JP JP2015505012A patent/JP2015512929A/ja active Pending
- 2013-04-10 EP EP13717801.8A patent/EP2836198A2/de not_active Withdrawn
- 2013-04-10 MX MX2014011576A patent/MX2014011576A/es unknown
- 2013-04-10 IN IN2133MUN2014 patent/IN2014MN02133A/en unknown
-
2017
- 2017-11-30 JP JP2017230525A patent/JP2018058881A/ja active Pending
- 2017-12-15 AU AU2017276321A patent/AU2017276321A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013153349A2 (en) | 2013-10-17 |
| CN104271112A (zh) | 2015-01-07 |
| RU2014144145A (ru) | 2016-06-10 |
| JP2015512929A (ja) | 2015-04-30 |
| WO2013153349A3 (en) | 2014-01-30 |
| MX2014011576A (es) | 2014-11-21 |
| US9402854B2 (en) | 2016-08-02 |
| AU2017276321A1 (en) | 2018-01-18 |
| EP2836198A2 (de) | 2015-02-18 |
| AU2013246692A1 (en) | 2014-10-02 |
| US20150080358A1 (en) | 2015-03-19 |
| KR20150002774A (ko) | 2015-01-07 |
| RU2678992C2 (ru) | 2019-02-05 |
| CA2869355A1 (en) | 2013-10-17 |
| JP2018058881A (ja) | 2018-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2749277A3 (de) | Pharmazeutische Zusammensetzung von Glycopyrronium und Vilanterol | |
| WO2014016548A3 (en) | Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient | |
| MY179703A (en) | Dry powder formulation comprising a phosphodiesterase inhibitor | |
| UA109661C2 (uk) | Фармацевтична композиція співкристалів трамадолу і коксибів | |
| IN2015DN03219A (de) | ||
| TN2012000566A1 (en) | Dry powder formulation comprising an antimuscarinic drug | |
| PH12016500433A1 (en) | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine | |
| MX2019003249A (es) | Diagnostico, prevencion y tratamiento de enfermedades de la articulacion. | |
| WO2014064410A3 (en) | Pharmaceutical composition comprising tiotropium and a hydrofluoroalkane | |
| UA107550C2 (uk) | Похідні естра-1,3,5(10),16-тетраєн-3-карбоксаміду, способи їх одержання, фармацевтичні препарати, що їх містять, та їх застосування для виготовлення лікарських засобів | |
| IN2015DN03854A (de) | ||
| MY165888A (en) | Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation | |
| TR201000733A2 (tr) | Flutikazon, tiotropyum ve sodyum kromoglikat içeren farmasötik bileşimler. | |
| WO2014007772A3 (en) | Inhalation compositions comprising glucose anhydrous | |
| WO2014007781A3 (en) | Inhalation compositions | |
| MX357556B (es) | Composiciones acuosas que comprenden arbekacina. | |
| WO2016025671A3 (en) | Treatment of sleep apnea with a combination of a carbonic anhydrase inhibitor and an aldosterone antagonist | |
| IN2014MN02133A (de) | ||
| PH12019500787A1 (en) | Nebulizable compositions of tiotropium and formoterol | |
| WO2013181217A3 (en) | Novel compounds and compositions for treatment of breathing control disorders or diseases | |
| EP2763687A4 (de) | Verfahren und zusammensetzungen zur behandlung des stoffwechselsyndroms sowie von obstruktiven atemwegserkrankungen, krebs und verwandten erkrankungen | |
| PH12015501179A1 (en) | Fixed dose pharmaceutical composition comprising mometasone and azelastine | |
| MX2014001940A (es) | Producto farmaceutico de aerosol para administracion por inhalacion oral o nasal. | |
| TN2013000015A1 (en) | Dry powder formulation comprising a phosphodiesterase inhibitor | |
| IN2013MU01242A (de) |